Behzad Aghazadeh

Develops drugs for the treatment of cancer

Acts as Hedge Fund

AB is a research-driven investment adviser that is global in scope and client-centered in their approach. The firm’s global team of research professionals, whose disciplines include economics, fundamental equity, fixed income and quantitative research, gives them a competitive advantage in achieving investment success for their clients. Within these research disciplines, they also have investment professionals that focus on multi-asset, wealth management and alternative investment strategies.

Functions as a College/University

Functions as a College/University

Sio Capital aims to invest capital in a global, healthcare-focused portfolio in order to generate attractive returns for their investors. The firm has a ‘value’ orientation with a strong attention to balance sheet quality and cash flow generation. Their long portfolios typically include growth at a reasonable price (GARP) and growth investments when attractive opportunities arise. For Sio Capital’s portfolios of short investments, they look for shorts that are ‘hyped up’ and whose valuations are predicated on expectations that the firm believes to be unattainable.

Provides business strategy consulting services

venBio invests in companies located in the United States. The firm focuses on companies operating in the fields of life sciences sectors. It participates in early to late stage transactions. The firm acts as a lead investor.

AVCAP aims to achieve attractive returns with moderate risk. The firm invests primarily in the equity, debt and associated derivatives of companies operating in the life sciences sector and related industries with a focus on publicly traded, and late-stage private biotechnology companies.